Activation of this pathway is known to act on astrocytes, microglia, and neurons to suppress neuroinflammation and promote neuroplasticity [102], and indeed, intranasal administration of insulin has shown benefit in several Phase 2 AD trials [60,61,62]. The gene discussed is INS; the disease is Alzheimer disease.